XOMAO
XOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
XOMAO Stock Analysis: Buy, Sell, or Hold?
$25.00
+0.02 (+0.08%)
â˛
5d:
+0.16%
30d:
-1.57%
90d:
-4.01%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (66%)
Quality Score
52/100
Position
FAIR
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$25.32 / $25.44
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: XOMAO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When XOMAO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: XOMAO is currently trading at $25.00, which is considered fair based on recent price action.
Technical Outlook: Technically, XOMAO is showing sideways momentum. The price is currently testing key support at $25.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XOMAO is showing sideways momentum. The price is currently testing key support at $25.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
52/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
65.9%
Trading Range & Key Levels
Support Level
$25.32
Resistance Level
$25.44
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Revenue Growth (YoY)
-22.6%
Earnings Growth (YoY)
207.9%
Profit Margin
69.6%
Share XOMAO Analysis
Share this live XOMAO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 13, 2026 5:03 AM ET
Data refreshes hourly during market hours. Next update: 6:03 AM
Data refreshes hourly during market hours. Next update: 6:03 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XOMAO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 50 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
RAPP
Rapport Therapeutics, InâĻ |
STRONG BUY
16 analysts |
$64 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive XOMAO Research Pages
